Erste Asset Management Gmb H Aurinia Pharmaceuticals Inc. Transaction History

Erste Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 26, 2024	SELL	$5.94 - $11.27 $356,400 - $676,200	-60,000 Closed	0 $0
Q4 2022 Nov 26, 2024	SELL	$4.11 - $8.14 $246,600 - $488,400	-60,000 Closed	0 $0
Q3 2022 Nov 26, 2024	BUY	$6.66 - $12.39 $399,600 - $743,400	60,000 New	60,000 $447 Million
Q2 2022 Nov 26, 2024	BUY	$8.95 - $12.8 $537,000 - $768,000	60,000 New	60,000 $617 Million
Q1 2022 Nov 22, 2024	BUY	$10.05 - $22.48 $301,500 - $674,400	30,000 Added 100.0%	60,000 $743 Million
Q4 2021 Nov 22, 2024	BUY	$17.78 - $33.08 $533,400 - $992,400	30,000 New	30,000 $675 Million
Q4 2020 Nov 22, 2024	SELL	$12.94 - $16.05 $789,340 - $979,050	-61,000 Reduced 67.03%	30,000 $418 Million
Q3 2020 Nov 22, 2024	BUY	$13.19 - $16.66 $1.2 Million - $1.52 Million	91,000 New	91,000 $1.32 Billion
Q4 2019 Nov 22, 2024	BUY	$3.88 - $21.42 $256,080 - $1.41 Million	66,000 New	66,000 $1.41 Billion

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.37B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.